Cancer of the Skin

Spitz nevus

Key Points Spitz nevi can be clinically and histopathologically distinguished from melanoma in a large majority of cases. Spitz nevi are predominantly seen in children and young adults, but recent studies have shown a broader age range than was previously…

Genetic Testing for Melanoma

Key Points Approximately 10% of melanomas occur in family clusters. In North American populations, mutations in the CDKN2A gene are associated with up to a 76% lifetime risk for melanoma. CDKN2A may also increase the risk for pancreatic cancer to…

Pregnancy and Melanoma

Key Points Pregnancy does not have an adverse effect on the prognosis of patients with stage I/II melanoma. There is some evidence that pregnant patients are diagnosed with thicker melanomas compared with non-pregnant controls, but this finding needs further study.…

Management of the Patient with Melanoma

Key Points Melanoma management should be tailored to the needs of each individual patient. Surgical excision is the cornerstone of melanoma management. Sentinel lymph node biopsy is currently a staging and prognostic tool in the management of melanoma. Adjuvant therapy…

Prognostic Factors and Staging in Melanoma

Key Points Staging has significant impact on prognostic assessement, treatment decision-making, and clinical trial planning and analysis. Primary tumor (Breslow) thickness and ulceration continue to represent important prognostic factors for survival and define T-category strata in cutaneous melanoma. Mitotic rate,…